[TORONTO, September 28] – Novel Biotechnology Inc., an innovative biotechnology start-up headquartered in Canada, is pleased to announce the successful completion of its $2.5 million seed round funding. This significant milestone was achieved with the support of angel investors, along with the Ontario Center of...

Tony has over 39 years’ experience in the development of manufacturing process and production of investigational biotherapeutics, 29 of these years, have been predominantly spent in the field of gene therapy and has been in the development of manufacturing processes for 4 licensed products including...

Novel Biotechnology Inc., a biotech company developing new solutions for plasmid DNA manufacturing - a critical starting material for gene therapy, cell engineering, mRNA therapy and vaccine applications - is pleased to welcome Matthew Weinstock, PhD as Chief Technology Officer. Dr. Weinstock is an accomplished biotech...

A plasmid is a small circular DNA molecule found in bacteria and some other microscopic organisms. Plasmids are physically separate from chromosomal DNA and replicate independently. They typically have a small number of genes — notably, some associated with antibiotic resistance — and can be...